wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q54322737-772DB96C-9057-4EEF-A7BF-6C4BED69CEE0
Q54322737-772DB96C-9057-4EEF-A7BF-6C4BED69CEE0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54322737-772DB96C-9057-4EEF-A7BF-6C4BED69CEE0
Clinical study of the novel cyclin-dependent kinase inhibitor dinaciclib in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia patients.
P2860
Q54322737-772DB96C-9057-4EEF-A7BF-6C4BED69CEE0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54322737-772DB96C-9057-4EEF-A7BF-6C4BED69CEE0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8dab3ff2e46c1030f61cf7ee53f8298c811ff5ae
P2860
The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase inhibitor, is dependent on p53 signaling